MyFinsight
Home
Blog
About
Contact
Download
Download image
Net income
$493,700K
(0.20%↑ Y/Y)
Depreciation
$168,600K
(11.07%↑ Y/Y)
Changes in other assets
and liabilities
-$108,100K
(-378.32%↓ Y/Y)
Stock-based compensation
$23,800K
(27.27%↑ Y/Y)
Increase in accounts
payable
$17,900K
(517.24%↑ Y/Y)
Asset impairments
$11,700K
(60.27%↑ Y/Y)
Decrease (increase) in
other current assets
-$9,700K
(-267.24%↓ Y/Y)
Decrease (increase) in
accounts receivable
-$6,900K
(-111.73%↓ Y/Y)
Non-cash restructuring
charges
$5,400K
Amortization
$2,800K
(-22.22%↓ Y/Y)
Pension and other
retirement plans, net
$600K
(130.00%↑ Y/Y)
Net cash provided by
operating activities
$754,800K
(15.52%↑ Y/Y)
Effect of exchange
rates on cash
$22,900K
(207.01%↑ Y/Y)
Canceled cashflow
$94,400K
Net increase
(decrease) in cash and cash...
$306,700K
(183.05%↑ Y/Y)
Canceled cashflow
$471,000K
(increase) decrease in
inventories
$62,800K
(249.52%↑ Y/Y)
Deferred income taxes
-$13,700K
(-291.43%↓ Y/Y)
Equity in
undistributed earnings of...
$10,500K
(-21.64%↓ Y/Y)
Other, net
$7,400K
(57.45%↑ Y/Y)
Proceeds from
stock-based compensation...
$11,300K
(-55.69%↓ Y/Y)
Employee stock purchase
plan contributions
$6,900K
(-4.17%↓ Y/Y)
Net cash used in
investing activities
-$285,900K
(24.50%↑ Y/Y)
Net cash used in
financing activities
-$185,100K
(70.27%↑ Y/Y)
Canceled cashflow
$18,200K
Capital expenditures
$285,900K
(-24.16%↓ Y/Y)
Shares purchased under
share repurchase...
$134,000K
(-76.11%↓ Y/Y)
Dividend payments
$61,200K
(3.55%↑ Y/Y)
Excise tax payments
$4,200K
(110.00%↑ Y/Y)
Shares repurchased for
employee tax...
$2,800K
(-50.88%↓ Y/Y)
Principal repayments on
finance leases
$1,100K
(-95.28%↓ Y/Y)
Back
Back
Cash Flow
source: myfinsight.com
WEST PHARMACEUTICAL SERVICES INC (WST)
WEST PHARMACEUTICAL SERVICES INC (WST)